13F-HR filed by Vestal Point Capital, LP
Vestal Point Capital, LP filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 73 holding rows worth $1,686,706,108.
- Accession
- 0001974915-25-000002
- Filer
- CIK 1974915
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 73 entries on the cover page, a total value of $1,686,706,108 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,686,706,108 with VALUE read as dollars as filed, 13F file number 028-23784. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 975,000 | $120,071,250 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 2,350,000 | $110,544,000 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 800,000 | $79,584,000 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 520,000 | $71,588,400 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 1,500,000 | $63,105,000 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 900,000 | $62,136,000 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 860,000 | $56,527,800 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 3,025,000 | $53,421,500 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 1,060,000 | $47,647,000 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 600,000 | $46,968,000 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 1,725,000 | $46,782,000 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 1,075,000 | $45,461,750 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 6,275,000 | $44,615,250 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 4,770,000 | $40,401,900 | dollars as filed | |
| GERON CORP | 374163103 | COM | 11,000,000 | $38,940,000 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 4,180,000 | $37,369,200 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 475,000 | $36,427,750 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 750,000 | $36,172,500 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 1,000,000 | $33,820,000 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 10,775,000 | $33,079,250 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 810,000 | $31,752,000 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 3,350,000 | $31,557,000 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 475,000 | $31,122,000 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 250,000 | $30,397,500 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 95,000 | $29,314,150 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 325,000 | $26,880,750 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 1,075,000 | $23,435,000 | dollars as filed | |
| NYXOAH S A | B6S7WD106 | SHS | 2,924,216 | $23,393,728 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 495,000 | $22,987,800 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 595,000 | $20,801,200 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 1,760,000 | $20,697,600 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 1,440,000 | $18,244,800 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 1,630,000 | $17,359,500 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 475,000 | $15,456,500 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 1,250,000 | $14,787,500 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 20,000 | $14,246,600 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 300,000 | $13,821,000 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 990,000 | $13,761,000 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 710,000 | $12,368,200 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 5,600,000 | $11,984,000 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 2,850,000 | $11,400,000 | dollars as filed | |
| AGILENT TECHNOLOGIES INC COM | 00846U101 | Stock | 75,000 | $10,075,500 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 11,500,000 | $9,846,300 | dollars as filed | |
| PERRIGO CO PLC SHS | G97822103 | Stock | 375,000 | $9,641,250 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 485,000 | $9,137,400 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 1,200,000 | $7,896,000 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 300,000 | $7,857,000 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 305,000 | $7,707,350 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 1,230,000 | $6,974,100 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 900,000 | $6,912,000 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 525,000 | $6,121,500 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 635,000 | $5,461,000 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 180,000 | $4,950,000 | dollars as filed | |
| CHIMERIX INC COM | 16934W106 | Stock | 1,400,000 | $4,872,000 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 2,570,000 | $4,728,800 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 2,000,000 | $4,380,000 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 2,465,000 | $4,067,250 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 915,000 | $3,870,450 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 645,000 | $3,637,800 | dollars as filed | |
| PASSAGE BIO INC | 702712100 | COM | 6,100,000 | $3,459,310 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 1,500,000 | $3,195,000 | dollars as filed | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 50,000 | $3,117,500 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 425,000 | $2,949,500 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 185,000 | $2,708,400 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 370,000 | $2,460,500 | dollars as filed | |
| BAUSCH HEALTH COS INC COM | 071734107 | Stock | 250,000 | $2,015,000 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 80,000 | $1,828,800 | dollars as filed | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 1,500,000 | $1,710,000 | dollars as filed | |
| ATARA BIOTHERAPEUTICS INC | 046513206 | COM NEW | 125,000 | $1,663,750 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 45,000 | $1,114,650 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 280,000 | $910,000 | dollars as filed | |
| TRAWS PHARMA INC | 68232V884 | COM NEW | 75,000 | $666,000 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 55,189 | $341,620 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001974915-25-000002 | this filing | 2025-02-14 | acceptance time not in the bulk data set |